AS902330
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AS902330, covering 2014-08-05 to 2014-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement [Phase 1]